ESC 365 - Effects of the glucagon like peptide- 1 receptor agonist on arterial stiffness, LV myocardial deformation and oxidative stress in newly diagnosed type 2 diabetes after 6-month treatment.

ESC Premium Access

Effects of the glucagon like peptide- 1 receptor agonist on arterial stiffness, LV myocardial deformation and oxidative stress in newly diagnosed type 2 diabetes after 6-month treatment.

Session: Diabetes - The malfunction of the "sweet heart"

Topic: Pharmacotherapy

Speaker: Doctor I. Ikonomidis (Athens, GR)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Ignatios Ikonomidis

National & Kapodistrian University of Athens, Athens (Greece)

5 presentations

3 followers

3 more presentations in this session

Diabetes and malfunction of the heart - Current knowledge

Speaker: Professor R. Ritchie (Melbourne, AU)

Non-ischemic myocardial lesions in type 2 diabetes mellitus as assessed by late gadolinium enhancement magnetic resonance imaging: a cohort study of lesion types and prevalence

Speaker: Doctor A. Bojer (Gentofte, DK)

How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus?

Speaker: Doctor A. Bosch (Erlangen, DE)

Access the full session

Diabetes - The malfunction of the "sweet heart"

Speakers: Doctor I. Ikonomidis, Professor R. Ritchie, Doctor A. Bojer, Doctor A. Bosch

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources